Gentamicin Sulfate

Manufacturer
Physicians Total Care, Inc.
Effective date
2011-03-09
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:11:27

Label at a glance#

ProductGentamicin Sulfate
Active ingredientGENTAMICIN SULFATE
Label structure10 sections

Indications and uses

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE: Gentamicin...

Dosage and administration

A small amount of GENTAMICIN OINTMENT or CREAM should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of GENTAMICIN OINTMENT or CREAM to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infect...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION

DESCRIPTION SECTION

Each gram of GENTAMICIN CREAM contains gentamicin sulfate equivalent to 1 mg of gentamicin base in a cream base of: methylparaben, butylparaben, stearic acid, cerasynt PA (propylene glycol monostearate), isopropyl myristate, propylene glycol, polysorbate 40, sorbitol solution and water. Each gram of GENTAMICIN OINTMENT contains gentamicin sulfate equivalent to 1 mg of gentamicin base in a base of: Light Mineral Oil and White Petrolatum, with 0.5 mg methylparaben and 0.1 mg propylparaben as preservatives.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

GENTAMICIN, a wide spectrum antibiotic provides highly effective topical treatment in primary and secondary bacterial infections of the skin. This product may clear infections that have not responded to other topical antibiotic agents. In impetigo contagiosa and other primary skin infections, treatment with a small amount of GENTAMICIN OINTMENT AND CREAM three to four times daily usually clears the lesions promptly. In secondary skin infections, the product facilitates the treatment of the underlying dermatosis by controlling the infection. Bacteria susceptible to the action of GENTAMICIN include sensitive strains of streptococci (group A beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-negative bacteria, Pseudomonas aeruginosa, Aerobacter aerogens, Escherichia coli, Proteus vulgaris and Klebsiella pneumoniae.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE: Gentamicin is a bactericidal agent that is not effective against viruses or fungi in skin infections. It is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions and wounds from minor surgery. Patients sensitive to neomycin can be treated with GENTAMICIN, although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic. GENTAMICIN CREAM is recommended for wet, oozing primary infections, and greasy, secondary infections, such as pustular acne or infected seborrheic dermatitis, and where a water washable cream preparation is desired. GENTAMICIN OINTMENT helps retain moisture and has been useful in infection on dry eczematous or psoriatic skin. GENTAMICIN CREAM and OINTMENT have been used successfully in infants over one year of age as well as in adults and children.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This product, GENTAMICIN OINTMENT AND CREAM is contraindicated in individuals with a history of sensitivity reactions to any of its components.

PRECAUTIONS

PRECAUTIONS SECTION

Use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with GENTAMICIN should be discontinued and appropriate therapy instituted.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

In patients with dermatoses treated with GENTAMICIN, irritation (erythema and pruritus) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with gentamicin on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of gentamicin followed by exposure to ultraviolet radiation.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

A small amount of GENTAMICIN OINTMENT or CREAM should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of GENTAMICIN OINTMENT or CREAM to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to GENTAMICIN under gelatin packing.

HOW SUPPLIED

HOW SUPPLIED SECTION

GENTAMICIN CREAM is supplied in

15 gram tube
NDC 54868-3524-0
30 gram tube
NDC 54868-3524-1

Store at controlled room temperature 15°-30°C (59°-86°F).

MANUFACTURED
BY PERRIGO
BRONX, NY 10457

1C800 RC J2


Relabeling of "Additional" barcode label by:
Physicians Total Care, Inc.
Tulsa, OK       74146

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GENTAMICIN CREAM

30 gram

image of 30 gram package labelimage of 30 gram package label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
197735gentamicin sulfate 0.1 % Topical CreamPSN1
197735gentamicin 1 MG/ML Topical CreamSCD1
197735gentamicin (as gentamicin sulfate) 0.1 % Topical CreamSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GENTAMICIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
Data codeCode 128352403000003524.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3b7b3a7a-635f-32a3-0c6c-7ad028e3de91Product name220250107
43025f0d-698c-68da-cec9-ea4261a7ef7aProduct name220250107
d3946667-8212-d1f2-67e1-5643a329bb56Product name220200403
4ce5dce5-e8a7-e4f6-0059-b527e4307477Product name220190501
48b05f5d-d2fc-45ab-76e8-3cb5bd44890dProduct name120140508
6084a4f4-5437-c9a5-caec-5361ee075a59Product name120140508
90c5639a-61b0-88d6-ddcf-21888e94869aProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
54868-3524-02019-09-24C16284748780-19350213a-493a-c013-e053-90daa90a1393210dde2f-6ea0-4068-8f6c-b9d62c67d12a
54868-3524-12019-09-24C16284748780-19350213a-493a-c013-e053-90daa90a1393210dde2f-6ea0-4068-8f6c-b9d62c67d12a

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54868-3524-0Gentamicin Sulfate1 in 1 CARTONCREAM11
54868-3524-0Gentamicin Sulfate15 g in 1 TUBECREAM151
54868-3524-1Gentamicin Sulfate30 g in 1 TUBECREAM301
54868-3524-1Gentamicin Sulfate1 in 1 CARTONCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54868-3524GENTAMICIN SULFATE CREAM [PHYSICIANS TOTAL CARE, INC.]14 package rows20110309_210dde2f-6ea0-4068-8f6c-b9d62c67d12a.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54868-3524-0GM - Gram54868-35248688d6fc-43c6-47cd-9ffc-fc23fe4d5ace12012-07-24
54868-3524-1GM - Gram54868-35243171b3ad-bd90-4e73-a43b-0a5e01c6fb4812012-07-24
45802-056-11GM - Gram45802-05663bbae86-a2c8-4c87-97c8-4e095a9de49212012-07-24
45802-056-35GM - Gram45802-0563629159e-c462-454d-aa64-f1d2ea2fa3c312012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
GENTAMICIN SULFATEACTIVE INGREDIENT8X7386QRLV1
GENTAMICINACTIVE MOIETYT6Z9V48IKG1
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV81
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
POLYSORBATE 40INACTIVE INGREDIENTSTI11B5A2X1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V31
PROPYLENE GLYCOL MONOSTEARATEINACTIVE INGREDIENTF76354LMGR1
SORBITOLINACTIVE INGREDIENT506T60A25R1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54868-352454868-3524-0, 54868-3524-1
45802-056

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOL MONOSTEARATEPROPYLENE GLYCOL MONOPALMITOSTEARATEF76354LMGRCREAM / TOPICAL9.3 %w/wExact identifier — unii+route+dosage form
POLYSORBATE 40POLYSORBATE 40STI11B5A2XCREAM / TOPICAL3 %w/wExact identifier — unii+route+dosage form
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii+route+dosage form
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSCREAM / TOPICAL65000 mgExact identifier — unii+route+dosage form
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii+route+dosage form
METHYLPARABENMETHYLPARABENA2I8C7HI9TCREAM / TOPICAL3000 mgExact identifier — unii+route+dosage form
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8CREAM / TOPICAL0.4 %w/wExact identifier — unii+route+dosage form
SORBITOLSORBITOL506T60A25RCREAM / TOPICAL36.8 %w/wExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062307-001GENTAMICIN SULFATEGENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A062307-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982c2088c7a36db…
2026-09-14 22:38:342026-08A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062307-001GENTAMICIN SULFATEEQ 0.1% BASECREAM / TOPICALATRS, Approved before 19823a93d1ddd44b…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A062307-001AT1c2088c7a36db…
2026-09-14 22:38:342026-08A062307-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A062307-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062307-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062307-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062307-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062307-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062307-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062307-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062307-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062307-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062307-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062307-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062307-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062307-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062307-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062307-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062307-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062307-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062307-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062307-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062307-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062307-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062307-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A062307-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062307-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062307-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062307-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A062307-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A062307-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062307-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062307-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062307-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062307-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062307-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062307-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062307-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A062307-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A062307-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062307-001AT13a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gentamicin SulfateGENTAMICIN SULFATEPadagis Israel Pharmaceuticals Ltd4cfbe37e-11d6-46fc-b287-0561387b17b72023-01-31Adverse reactionsExact identifier
ndc (product): 45802-056
b11256fa-aab4-452f-83e4-4447fdbd63e7210dde2f-6ea0-4068-8f6c-b9d62c67d12a2011-03-09Adverse reactionsExact identifier
spl id: b11256fa-aab4-452f-83e4-4447fdbd63e7
spl set id: 210dde2f-6ea0-4068-8f6c-b9d62c67d12a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.